glp 1 drugs sleep apnea Survey: Providers Want GLP-1s Approved for How to Treat Moderate Sleep
Description
Kang, J
L.et al (2020)
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy [Internet]
I think something is changing in the reward pathway in the brain. GLP-1 drugs like semaglutide stimulate the production of insulin, which can cross the blood-brain barrier
Thus, this modest increase in LDL-C may be misleading regarding ASCVD risk, as patients with obesity may have a higher concentration of atherogenic small, dense LDL particles, and therefore high levels of apoB for a given blood LDL-C [10, 13]
Studies were awarded stars for each criterion, with a maximum of nine stars indicating the highest quality
